Amphastar Pharmaceuticals Patents – Insights & Stats (Updated 2023)
Amphastar Pharmaceuticals has a total of 211 patents globally, out of which 125 have been granted. Of these 211 patents, more than 45% patents are active. China is where Amphastar…
Amphastar Pharmaceuticals has a total of 211 patents globally, out of which 125 have been granted. Of these 211 patents, more than 45% patents are active. China is where Amphastar…
Aavantibio has a total of 12 patents globally. Of these 12 patents, more than 91% patents are active. Parallelly, United States of America seems to be the main focused R&D…
Meissa Vaccines has a total of 12 patents globally, out of which no patents have been granted. Of these 12 patents, more than 91% patents are active. Parallelly, United States…
Veramorph has a total of 3 patents globally. Of these 3 patents, more than 66% patents are active. The United States of America and Europe (EPO) are where Veramorph has…
Umoja Biopharma has a total of 59 patents globally, out of which no patents have been granted. Of these 59 patents, more than 88% patents are active. Europe is where…
Fzata has a total of 13 patents globally, out of which no patents have been granted. Of these 13 patents, more than 76% patents are active. Canada is where Fzata…
White Sands Pharma has a total of 9 patents globally, out of which 5 have been granted. Of these 9 patents, more than 77% patents are active. The United States…
Johnson & Johnson has a total of 108258 patents globally, out of which 59801 have been granted. Of these 108258 patents, more than 68% patents are active. United States of…
Ashvattha Therapeutics has a total of 63 patents globally, out of which 1 have been granted. Of these 63 patents, more than 88% patents are active. The United States of…
Faraday Pharmaceuticals has a total of 39 patents globally, out of which 7 have been granted. Of these 39 patents, more than 33% patents are active. The United States of…
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.